MISSOULA, Mont.--( BUSINESS WIRE )--OSRX, Inc. today expressed its profound disappointment with the recent jury verdict in the case of ImprimisRx, LLC v. OSRX, Inc. The company believes the decision to be unjust and not based on the facts presented during the trial. Despite this setback, OSRX remains resolute in its commitment to challenge this outcome and address the significant issues that persist. “ Leading up to the trial, OSRX won summary judgment on ImprimisRx’s false advertising claims, a

FORT MYERS, Fla., Nov. 22, 2024 /PRNewswire/ -- A landmark in cancer treatment has come full circle, as the U.S. Food and Drug Administration (FDA) approved revumenib, a revolutionary drug for relapsed or refractory acute leukemia with a KMT2A translocation on November 15, 2024. This life-saving therapy, first administered to a Florida Cancer Specialists & Research Institute, LLC (FCS) patient at its Sarasota Drug Development Unit (DDU) in 2019 as part of a Phase 1 clinical trial, is now availab

DUBLIN--( BUSINESS WIRE )--The "B-cell Lymphoma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This "B-cell Lymphoma- Pipeline Insight, 2024" report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and mo

TailorMed, a platform that allows healthcare providers to manage their finances, check health plans and estimate out-of-pocket costs for uninsured patients, announced a $40 million financing round, combining equity and debt, led by Windham Capital Partners. Samsung Next, BrightEdge, Citi Impact Fund and the investment arms of OSF Healthcare, Ballad Ventures, Inception Health, UnityPoint Health Ventures, UH Ventures and Providence Ventures also participated in the round. The company also receive

DUBLIN--( BUSINESS WIRE )--The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" conference has been added to ResearchAndMarkets.com's offering. The US is the largest market globally for pharmaceutical sales, so having a good understanding of FDA procedures is vital for those submitting in this challenging region. This course will help clarify the US regulatory process, giving you a practical insight into FDA requirements and ensuring that you are fully up to date wi

Researchers at the University of California San Diego say they developed a new, improved wearable ultrasound patch for monitoring blood pressure. The researchers say it’s the first wearable ultrasound blood pressure sensor to undergo rigorous and comprehensive clinical validation on over 100 patients. According to the researchers, the patch could improve the quality of cardiovascular health monitoring in the clinic and the home. They They published their findings in Nature Biomedical Engineering

Historically, trust between doctors and patients has grown, especially as care delivery became more advanced and mortality rates decreased. But more recently, the COVID-19 crisis has been associated with a decrease in trust in physicians and hospitals, according to some research, and has threatened public confidence in the U.S. healthcare system. Many healthcare experts see promise in artificial intelligence – and hope AI will enable providers to reach more patients and improve health outcomes.

AVON, Ind., Nov. 22, 2024 /PRNewswire/ -- The Center for Pain Management (CFP) is pleased to announce its upcoming move to a state-of-the-art facility at 7950 Ortho Lane in Brownsburg, IN, scheduled for early Spring 2025. The new location will replace the current clinic at 97 Dover Street in Avon, IN, and offer over 13,000 square feet of expanded clinical space, including a dedicated physical therapy area, psychology offices, and an on-site surgery center. This relocation reflects the Center for

Sanofi is proposing a new model for distributing drug discounts under the federal 340B program, according to the Wall Street Journal , in an effort that is almost certain to create pushback from the government. The drugmaker’s plan would have certain hospitals order 340B drugs at full price, then recoup discounts later after Sanofi verifies certain claims data, according to the WSJ. Sanofi declined to comment on its plans, and some details remain unclear. Johnson & Johnson and Eli Lilly have

BROWNSBURG, Ind., Nov. 22, 2024 /PRNewswire/ -- American Pain Consortium (APC), a leading provider of management and support services for specialized, Interventional Pain Management practices, is excited to announce the opening of a new, state-of-the-art Ambulatory Surgery Center (ASC) on the west side of Indianapolis in Brownsburg, IN. The facility, Brownsburg Advanced Surgery Center, is designed to enhance access to advanced Interventional Pain Management treatments and further elevate the pat